NCT05454371

Investigation of Urinary Biomarkers for the Detection of Prostate Cancer

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Novosanis NV · Industry
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The aim of this study is to investigate and possibly validate urinary biomarkers for prostate cancer. During this study the focus will be on aberrations of selected genes as prognostic or predictive value has been shown for these genes in tissue, CTC or blood derived cfDNA. Proteins will be explored in urine as well. This is a prospective study in which urine samples will be collected from healthy volunteers and urine samples and a blood sample from cancer patients with prostate cancer. The participants will be asked to provide a urine sample collected with the ColliPee® device and fill out an online questionnaire to collect usability data. Thereafter, the urine sample will be aliquoted to be used in the study to investigate the different urinary analytes.

Conditions

• Prostate Cancer
• Urine
• Liquid Biopsy

Interventions

Type	Name	Description
DEVICE	Colli-Pee UAS devices	Colli-Pee UAS device variants will be evaluated during this study

Timeline

• Start date: 2023-12-01
• Primary completion: 2023-12-01
• Completion: 2023-12-01
• First posted: 2022-07-12
• Last updated: 2023-11-13

Locations

1 site across 1 country: Belgium